Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

THR

Thermon (THR)

Thermon Group Holdings Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NYSE:THR
DataHoraFonteTítuloCódigoCompanhia
04/06/202415:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:THRThermon Group Holdings Inc
30/05/202411:27Edgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:THRThermon Group Holdings Inc
29/05/202417:46Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:THRThermon Group Holdings Inc
29/05/202407:45Edgar (US Regulatory)Form 8-K - Current reportNYSE:THRThermon Group Holdings Inc
15/05/202417:01Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:THRThermon Group Holdings Inc
11/03/202414:14Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:THRThermon Group Holdings Inc
14/02/202412:04Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNYSE:THRThermon Group Holdings Inc
01/02/202419:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:THRThermon Group Holdings Inc
01/02/202412:27Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NYSE:THRThermon Group Holdings Inc
21/06/202311:25Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NYSE:THRThermon Group Holdings Inc
21/06/202311:23Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NYSE:THRThermon Group Holdings Inc
05/06/202316:55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:THRThermon Group Holdings Inc
31/05/202316:17Edgar (US Regulatory)Specialized Disclosure Report (sd)NYSE:THRThermon Group Holdings Inc
25/05/202307:45Edgar (US Regulatory)Current Report Filing (8-k)NYSE:THRThermon Group Holdings Inc
14/02/202318:11Edgar (US Regulatory)Statement of Ownership (sc 13g)NYSE:THRThermon Group Holdings Inc
09/02/202314:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:THRThermon Group Holdings Inc
06/02/202316:59Edgar (US Regulatory)Schedule 13g
(sc 13g/a)
NYSE:THRThermon Group Holdings Inc
03/11/202213:02Edgar (US Regulatory)Quarterly Report (10-q)NYSE:THRThermon Group Holdings Inc
26/05/202217:02Edgar (US Regulatory)Annual Report (10-k)NYSE:THRThermon Group Holdings Inc
23/02/202213:43Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NYSE:THRThermon Group Holdings Inc
04/02/202211:26Edgar (US Regulatory)Schedule 13gNYSE:THRThermon Group Holdings Inc
27/05/202118:14Edgar (US Regulatory)Amended Annual Report (10-k/a)NYSE:THRThermon Group Holdings Inc
09/04/202117:10Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NYSE:THRThermon Group Holdings Inc
18/11/202008:04Edgar (US Regulatory)Notice of Effectiveness (effect)NYSE:THRThermon Group Holdings Inc
27/07/202018:23Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NYSE:THRThermon Group Holdings Inc
11/06/201902:30GlobeNewswireONCURIOUS NV Receives Project Grant from VLAIO to Progress its Pipeline of Next Generation Cancer ImmunotherapiesNYSE:THRThermon Group Holdings Inc
06/06/201914:00GlobeNewswireOxurion NV - Data from a Phase 1/2 Clinical Study evaluating THR-317 (anti-PlGF) for DME presented at 2019 FLORetina MeetingNYSE:THRThermon Group Holdings Inc
30/05/201916:12Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NYSE:THRThermon Group Holdings Inc
08/05/201902:30GlobeNewswireOxurion NV : Oxurion NV Business Update - Q1 2019NYSE:THRThermon Group Holdings Inc
24/04/201902:30GlobeNewswireOxurion NV announces full enrollment in its Phase 1 trial evaluating the safety of its plasma kallikrein inhibitor THR-149 fo...NYSE:THRThermon Group Holdings Inc
 Apresentando as notícias mais relevantes sobre:NYSE:THR